TCM
ALNY icon

Teza Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Teza Capital Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,026
Closed -$602K – 571
2024
Q1 		$602K Sell
4,026
-7,396
-65% -$1.23M 0.08% 309
2023
Q4 		$2.19M Buy
+11,422
New +$1.95M 0.37% 71
2023
Q2 		– Sell
-1,735
Closed -$348K – 559
2023
Q1 		$348K Buy
+1,735
New +$365K 0.08% 352
2020
Q3 		– Sell
-7,437
Closed -$1.1M – 362
2020
Q2 		$1.1M Buy
7,437
+5,433
+271% +$732K 0.24% 123
2020
Q1 		$218K Sell
2,004
-717
-26% -$82.8K 0.7% 66
2019
Q4 		$313K Buy
+2,721
New +$271K 0.09% 412

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return